Re: Estimation of opioid misuse prevalence in New York State counties, 2007-2018. A Bayesian spatio-temporal abundance model approach - Takeaways - MDSpire

Re: Estimation of opioid misuse prevalence in New York State counties, 2007-2018. A Bayesian spatio-temporal abundance model approach

  • By

  • Heather Bradley

  • Trang Nguyen

  • Serveh Sharifi Far

  • Ashly E Jordan

  • Vivian Kamanu

  • Ruth King

  • Lanxin Li

  • Nicole Luisi

  • Stephanie Mack

  • Tomoko Udo

  • Eli S Rosenberg

  • January 28, 2025

  • 0 min

Share

  • 1

    The article critiques the opioid misuse prevalence estimates in New York State, highlighting inaccuracies in emergency department visit definitions.

  • 2

    Concerns are raised about the National Survey on Drug Use and Health's bias due to under-representation of certain populations.

  • 3

    Statewide opioid misuse estimates are lower than expected when compared to the sum of county-level estimates, indicating potential model issues.

  • 4

    The lack of age range descriptions for county-level inputs may have affected the accuracy of statewide prevalence estimates.

  • 5

    Public health-academic partnerships are essential for improving substance use outcome modeling and enhancing response strategies.

Original Source(s)

Re: Estimation of opioid misuse prevalence in New York State counties, 2007-2018. A Bayesian spatio-temporal abundance model approach

  • by Heather Bradley, Trang Nguyen, Serveh Sharifi Far, Ashly E Jordan, Vivian Kamanu, Ruth King, Lanxin Li, Nicole Luisi, Stephanie Mack, Tomoko Udo, Eli S Rosenberg

  • January 28, 2025

Related Content

Coverage Limitations for Use of Urine Drug Testing in a State Medicaid Program

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

The landscape of cocaine cytotoxicity and the role of sigma-1 receptor modulation and adulterant synergism